Correlation Between Immix Biopharma and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Immix Biopharma and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Anebulo Pharmaceuticals.
Diversification Opportunities for Immix Biopharma and Anebulo Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Immix and Anebulo is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Immix Biopharma and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Immix Biopharma is expected to generate 0.99 times more return on investment than Anebulo Pharmaceuticals. However, Immix Biopharma is 1.01 times less risky than Anebulo Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 207.00 in Immix Biopharma on November 9, 2024 and sell it today you would lose (5.00) from holding Immix Biopharma or give up 2.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Immix Biopharma |
| Anebulo Pharmaceuticals |
Immix Biopharma and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Anebulo Pharmaceuticals
The main advantage of trading using opposite Immix Biopharma and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |